Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dipender Gill

Showing results (271-280 of 325) with videos related to

Pageof 33
Sort By:
Nature Medicine|June 2, 2022
Transferability of genetic risk scores in African populationsAbram B Kamiza, Sounkou M Toure, Marijana Vujkovic, et al.
Circulation|February 3, 2025
Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization StudyStephen O Brennan, Peter J Kelly, Sarah Gorey, et al.
Cancer Research|September 28, 2014
Adiponectin receptor signaling on dendritic cells blunts antitumor immunityPeng H Tan, Helen E J Tyrrell, Liquan Gao, et al.
International Journal of Epidemiology|May 31, 2019
Sex hormone binding globulin and risk of breast cancer: a Mendelian randomization studyNiki L Dimou, Nikos Papadimitriou, Dipender Gill, et al.
Ebiomedicine|February 26, 2023
Mendelian randomization and clinical trial evidence supports TYK2 inhibition as a therapeutic target for autoimmune diseasesShuai Yuan, Lijuan Wang, Han Zhang, et al.
European Heart Journal|October 9, 2025
Blood pressure, plasma proteins, and cardiovascular diseases: a network Mendelian randomization and observational studyDevendra Meena, Jingxian Huang, Alexander Smith, et al.
Cardiovascular Research|May 10, 2025
RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: A drug-target Mendelian randomization studyEloi Gagnon, Dipender Gill, Jérôme Bourgault, et al.
Journal of the American Heart Association|June 29, 2021
Genetic Evidence for Repurposing of GLP1R (Glucagon-Like Peptide-1 Receptor) Agonists to Prevent Heart FailureIyas Daghlas, Ville Karhunen, Devleena Ray, et al.
Nature Communications|October 3, 2025
Author Correction: Cross-population GWAS and proteomics improve risk prediction and reveal mechanisms in atrial fibrillationShuai Yuan, Jie Chen, Xixin Ruan, et al.
Nature Communications|July 11, 2025
Cross-population GWAS and proteomics improve risk prediction and reveal mechanisms in atrial fibrillationShuai Yuan, Jie Chen, Xixin Ruan, et al.
Pageof 33

Showing results (271-280 of 325) with videos related to

Sort By:
Pageof 33
Nature Medicine|June 2, 2022
Transferability of genetic risk scores in African populationsAbram B Kamiza, Sounkou M Toure, Marijana Vujkovic, et al.
Circulation|February 3, 2025
Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization StudyStephen O Brennan, Peter J Kelly, Sarah Gorey, et al.
Cancer Research|September 28, 2014
Adiponectin receptor signaling on dendritic cells blunts antitumor immunityPeng H Tan, Helen E J Tyrrell, Liquan Gao, et al.
International Journal of Epidemiology|May 31, 2019
Sex hormone binding globulin and risk of breast cancer: a Mendelian randomization studyNiki L Dimou, Nikos Papadimitriou, Dipender Gill, et al.
Ebiomedicine|February 26, 2023
Mendelian randomization and clinical trial evidence supports TYK2 inhibition as a therapeutic target for autoimmune diseasesShuai Yuan, Lijuan Wang, Han Zhang, et al.
European Heart Journal|October 9, 2025
Blood pressure, plasma proteins, and cardiovascular diseases: a network Mendelian randomization and observational studyDevendra Meena, Jingxian Huang, Alexander Smith, et al.
Cardiovascular Research|May 10, 2025
RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: A drug-target Mendelian randomization studyEloi Gagnon, Dipender Gill, Jérôme Bourgault, et al.
Journal of the American Heart Association|June 29, 2021
Genetic Evidence for Repurposing of GLP1R (Glucagon-Like Peptide-1 Receptor) Agonists to Prevent Heart FailureIyas Daghlas, Ville Karhunen, Devleena Ray, et al.
Nature Communications|October 3, 2025
Author Correction: Cross-population GWAS and proteomics improve risk prediction and reveal mechanisms in atrial fibrillationShuai Yuan, Jie Chen, Xixin Ruan, et al.
Nature Communications|July 11, 2025
Cross-population GWAS and proteomics improve risk prediction and reveal mechanisms in atrial fibrillationShuai Yuan, Jie Chen, Xixin Ruan, et al.
Pageof 33